🇺🇸 FDA
Patent

US 11986454

Methods of providing solriamfetol therapy to subjects with impaired renal function

granted A61KA61K31/27A61K31/325

Quick answer

US patent 11986454 (Methods of providing solriamfetol therapy to subjects with impaired renal function) held by AXSOME MALTA LTD. expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME MALTA LTD.
Grant date
Tue May 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/27, A61K31/325, A61K9/0053, A61P